Home > Products > CEA & TNFα
> Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (CrossMab)
Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (CrossMab) (CAT#: CROSSAB-142)
Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget cytokine (TNFα) to tumor cells. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-TNFα Bispecific Antibody (CrossMab) (CROSSAB-142). Click the button below to contact us or submit your feedback about this product.